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Abstract Subglottic stenosis is rarely idiopathic. In this case report, a 40-year-old female patient presented with subglottic stenosis with an 
unidentified etiology along with bilateral bronchial stenosis. Hoarseness arose in the last 4 years in this patient, who was undergoing 
treatment because of asthma for 13 years. Her physical examination revealed the presence of bilateral rhonci. Her tomography analysis 
revealed tracheal stenosis in a 2-cm segment at the C6-7 level. Her bronchoscopy analysis revealed subglottic stenosis. White plaques 
were observed in the entire tracheobronchial tree; biopsy was performed and lavage was taken. Samples were sent for pathological 
and microbiological examinations. Stenosis in the bronchial system was clear in the left main bronchus entry and at the right 
intermediate bronchus level. Dilatation was performed. Chronic active inflammation and squamous hyperplasia were observed in the 
pathology of the biopsies. Growth did not occur in tuberculosis and nonspecific cultures. Reflux was not present in the gastrointestinal 
system examination. All serological and rheumatologic examinations performed were normal. Idiopathic subglottic stenosis is 
exceedingly rare. Bronchial system stenosis accompanying idiopathic tracheal stenosis is even rarer, and its treatment is difficult.
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INTRODUCTION
The general causes of tracheal stenosis are intubation, tracheostomy, chemical or basic damage, and trauma. Rarer, 
inflammatory diseases such as Wegener’s granulomatosis (WG), connective tissue diseases, and sarcoidosis can play 
roles in the etiopathogenesis. When all these causes are excluded, the diagnosis is idiopathic subglottic stenosis (ISS) 
[1]. ISS is a very rare disease, more commonly observed in women. In this study, an ISS case that constituted a difficul-
ty in treatment because of diffuse stenosis in both bronchial systems accompanying subglottic stenosis is presented.
CASE PRESENTATION
A 40-year-old female patient who was undergoing treatment for asthma underwent appendectomy 9 years ago. 
Prolonged intubation was not present. Hoarseness started in the last 4 years, nose bleeding occurred 2 weeks ago, and 
she was evaluated by an ear, nose, and throat expert. Sinusitis and nasal crusts were observed in the patient. After a 
recurrence of nose bleeding, indirect laryngoscopy was performed, and “stenosis in the subglottic area” was observed 
and she was directed to our polyclinic.
Bilateral rhonchus and stridor were present in her physical examination. Sedimentation and C-reactive protein values 
were normal in her blood analyses. There were no features in her chest radiography.
In the respiratory function test, FVC was measured as 3.48 l (71%), FEV1 as 3.01 l (65%), and FEV1/FVC as 87%. In her 
cervical and thoracic computed tomography, tracheal stenosis was observed in the narrowest part of an approximately 
2-cm segment at the C6-7 level, with a coronal diameter of 7.7 mm and a sagittal diameter of 12.1 mm (Figure 1). 
Endobronchial lesion was not detected. Subsegmental linear atelectasis appearance was present in the lower left pul-
monary lobe.
Fiberoptic bronchoscopy was performed to the patient with a provisional diagnosis of subglottic stenosis, as a way of 
planning prior to the surgical intervention. Stenosis that proceeded for subglottic 2-cm segment was observed in the 
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fiberoptic bronchoscopy (Figure 2). Diffuse white plaques 
that occasionally caused webs were observed in the entire 
tracheobronchial tree. Stenosis in the bronchial system was 
clear in the left main bronchus entry and at the right interme-
diate bronchus level (Figure 2). Because of diffuse stenosis, 
surgical intervention was abandoned, and rigid bronchosco-
py was performed in the same session. Biopsy was performed 
in stenosis areas and lavage was taken. Samples were sent for 
pathological and microbiological examinations. Dilatation 
was performed upon noticing, during rigid bronchoscopy, 
that the stenosis was not very stiff. The pathology of biopsy 
and lavage was reported as “chronic active inflammation and 
squamous hyperplasia.” Growth did not occur in tuberculo-
sis and nonspecific cultures. Mycobacteria polymerase chain 
reaction (PCR) studies were negative. Microorganisms were 
not observed in Gram staining, and fungal spores and hyphae 
were not observed in periodic acid-Schiff staining.
When the tomography of the patient was uploaded to the 
three-dimensional software and retrospectively re-examined, 
stenosis was observed in the bronchial systems as well in the 
coronal sections (Figure 1c).
Reflux was not present in the gastrointestinal system examina-
tion. Serological and rheumatologic examinations [anti-nucle-
ar antibody (ANA)= negative, cytoplasmic anti-neutrophil 
antibody (c-ANCA)= negative] did not return any pathological 
findings.
The complaints of the patient with respect to shortness of 
breath increased 6 months after bronchoscopic dilatation, 
and dilatation was performed again with rigid bronchoscopy, 
and mitomycin C attachment was performed. The patient 
developed complaint of hemoptysis 15 days after the surgery, 
and she was hospitalized and followed up for 2 days. During 
hospitalization and later follow-ups, hemoptysis complaints 
did not arise. The patient is being followed up without symp-
toms on the 8th month of the 2nd bronchoscopic dilatation. 
Written consents for every intervention performed were 
obtained from the patient. The obtained written consents 
included the potential scientific and educational use of the 
findings and images regarding her disease.
DISCUSSION
The most frequent causes of tracheobronchial system steno-
ses are intubation and tracheostomy. ISS is quite rare. In the 
study of Rubikas et al. [2] consisting of 75 laryngotracheal 
patients, only one patient’s diagnosis was ISS, and the cause 
of stenosis of 71 patients was intubation. The physiopatholo-
gy is not known in ISS; however, some authors claimed that 
gastroesophageal reflux, chronic coughing, and abnormal 
estrogen response can have influences [3]. On the other 
hand, its relationship with WG is emphasized in many stud-
ies and cases. It is reported that as much as 49% of the 
patients are diagnosed with ISS because of the absence of 
WG findings and symptoms [4]. There are even cases that 
were diagnosed as WG 20 years after the ISS diagnosis [5]. 
The case was examined for WG, and WG diagnosis was 
excluded. Nevertheless, her follow up continues in light of 
the literature.
The treatment of ISS is controversial because it is rarely seen 
and its physiopathology is unclear. Surgical treatment is still 
the first treatment choice, with success rates as high as 90% 
in subglottic stenoses associated with a benign factor [6]. 
Marcillo et al. [3] reported a 97% success rate with surgical 
correction in a study consisting of 64 cases with diagnoses of 
ISS. Endoscopic treatments are reported as good for palliation 
and as progressing with frequent recurrences in the long run 
[7]. There are also authors, most of which report achieving 
sufficient results with endoscopic treatment [8]. The type the 
endoscopic treatment methods to be performed is a contro-
versy. Mitomycin C application is frequently recommended 
in endoscopic applications [6]. Stent applications added to 
dilatation will yield longer palliation in the patient, and it can 
establish patient’s comfort without the need of tracheostomy 
or more invasive processes [9]. Radiological and clinical 
findings of the patient made us consider ISS; therefore, surgi-
cal treatment was planned following bronchoscopic evalua-
tion. However, bronchoscopy revealed that the patient not 
only had ISS but also bronchial stenoses. She therefore dif-
fered from the cases previously reported in the literature. 
Surgical treatment was not possible in our patient, and we 
performed bronchoscopic dilatation in the first admittance. In 
the second admittance, mitomycin C was administered 
alongside dilatation. Mitomycin C is an antineoplastic agent 
Figure 1. Thoracic CT sections. (a) Stenosis in the subglottic region in the transverse section. (b) Stenosis in the sagittal section is observed to 
be on a segment that is approximately 2 cm long. (c) Stenosis is observed in the left main bronchus in the coronal section.
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that inhibits fibroblast proliferation and modulates wound 
healing [10]. Good results of its application as a support for 
endoscopic treatment in trachea stenoses are reported [10]. 
The case was particularly observed to benefit from the sec-
ond dilatation (one where mitomycin C was performed). In 
the retrospective, radiological examination, in addition to the 
initial evaluation of radiologists, stenoses are observed in the 
left main bronchus as well in the coronal sections (Figure 1c). 
We maintain that although the treatment plan of tracheal 
diseases is being formed, it is crucial that the detailed radio-
logical examinations are conducted by radiology experts 
who are experienced in this subject.
Surgical correction is the first choice in cases of airway ste-
noses associated with a benign factor, if an emergency 
response is not required [6,8]. This case was not suitable for 
surgical treatment because of diffuse airway involvement. 
Dilatation is an important treatment choice in patients with 
submucosal or extrinsic lesions where curative surgery is not 
possible [8]. Similarly, dilatation is the first choice in cases 
with submucosal or extrinsic lesions who require an emer-
gency response, and stent is recommended in suitable 
patients [8]. Mechanical dilatation can provide sufficient 
treatment, particularly in cases with web-style ISS [1]. 
Bronchoscopic, radiological, and pathological findings of the 
case made us consider a submucosal-type stenosis, and no 
finding was detected regarding cartilaginous type-stenosis. 
Therefore, we maintain that the case benefited, at least par-
tially, from dilatation. Because of diffuse airway stenosis and 
the complexity of stenosis localizations, we initially did not 
consider stent application in our case. Stent application can 
be considered as a treatment option if stenosis recurs in our 
patient who is being followed up. In cases with cartilagi-
nous-type stenosis or with an exophytic lesion, curating with 
Figure 2. Bronchoscopic images. (a) Stenosis in the subglottic level. (b) Appearance in the carina level. (c) Stenosis in the left main bronchus. 
(d) Stenosis in the right intermediate bronchus.
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dilatation and endobronchial treatment modalities (laser, 
electrocautery, cryotherapy, photodynamic treatment etc.) are 
recommended [8]. Furthermore, surgical treatment proce-
dures can be performed depending on the etiological and 
pathological cause [2]. Endobronchial treatment modalities 
(preferably laser, because it is responsible for less mucosal 
damage) can be used in cases with submucosal stenosis in 
whom dilatation cannot be achieved via conventional meth-
ods (such as balloon and bougienage) [8]. Endobronchial 
treatment modalities were not required in our case where 
sufficient airway patency was established via mechanical 
dilatation. Stent was not considered because of the diffusive-
ness of the lesions.
Idiopathic subglottic stenosis is a rare condition, and there is 
no consensus regarding its treatment. Because of its slow 
progression, patients can undergo asthma treatment by mis-
take for a long time. We tried to administer endoscopic treat-
ment in our case that differed from other ISSs due to diffuse 
stenosis in the tracheobronchial system. We assume that, in 
tracheobronchial system stenoses, one must develop a treat-
ment strategy on a case-by-case basis and choose a treatment 
that is specific to the case. 
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